119 related articles for article (PubMed ID: 31095884)
1. Clinical characteristics of pulmonary hypertension patients living in plain and high-altitude regions.
Lei S; Sun Z; He X; Li C; Zhang Y; Luo X; Wu S
Clin Respir J; 2019 Aug; 13(8):485-492. PubMed ID: 31095884
[TBL] [Abstract][Full Text] [Related]
2. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
[TBL] [Abstract][Full Text] [Related]
3. [Investigation and analysis for current situation and pathogenesis relevant to pulmonary hypertension].
Lei S; Tang D; Xu N; Wu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):641-646. PubMed ID: 28690220
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of pulmonary hypertension in myelofibrosis.
Lopez-Mattei J; Verstovsek S; Fellman B; Iliescu C; Bhatti K; Hassan SA; Kim P; Gray BA; Palaskas NL; Grosu HB; Mamas MA; Faiz SA
Ann Hematol; 2020 Apr; 99(4):781-789. PubMed ID: 32076825
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
Ten Kate CA; Tibboel D; Kraemer US
Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682
[TBL] [Abstract][Full Text] [Related]
6. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
8. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
[TBL] [Abstract][Full Text] [Related]
9. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis.
Handa T; Nagai S; Ueda S; Chin K; Ito Y; Watanabe K; Tanizawa K; Tamaya M; Mishima M; Izumi T
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):27-35. PubMed ID: 21086902
[TBL] [Abstract][Full Text] [Related]
10. Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation.
Nowak J; Hudzik B; Niedziela J; Rozentryt P; Zembala M; Gąsior M
Transplant Proc; 2018 Sep; 50(7):2044-2047. PubMed ID: 30177106
[TBL] [Abstract][Full Text] [Related]
11. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
12. Cardiac biomarkers at high altitude.
Mellor A; Boos C; Holdsworth D; Begley J; Hall D; Lumley A; Burnett A; Hawkins A; O'Hara J; Ball S; Woods D
High Alt Med Biol; 2014 Dec; 15(4):452-8. PubMed ID: 25330333
[TBL] [Abstract][Full Text] [Related]
13. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
[TBL] [Abstract][Full Text] [Related]
14. [A correlation study of Tei index and N-terminal pro-brain natriuretic peptide in patients with high-altitude heart disease].
Li GY; Liu ZJ; Chen HJ; Zhang XH; Jiang JJ; Hu AZ
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):947-9. PubMed ID: 22333128
[TBL] [Abstract][Full Text] [Related]
15. NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension.
Amdani SM; Mian MUM; Thomas RL; Ross RD
Congenit Heart Dis; 2018 Jul; 13(4):499-505. PubMed ID: 29575641
[TBL] [Abstract][Full Text] [Related]
16. [Association between degree of pulmonary artery hypertension and cardiac structural and functional changes in chronic high altitude heart disease patients].
Dawaciren ; Gesangluobu ; Zhuomaciren ; Li K; Gusanglamu ; Zhang LJ; Cidanluobu ; Gesanggawa ; Dawa
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Sep; 41(9):761-5. PubMed ID: 24331805
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial.
Luchner A; Möckel M; Spanuth E; Möcks J; Peetz D; Baum H; Spes C; Wrede CE; Vollert J; Müller R; Katus H; Giannitsis E
Eur J Heart Fail; 2012 Mar; 14(3):259-67. PubMed ID: 22265921
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
[TBL] [Abstract][Full Text] [Related]
19. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.
Wang L; Wang F; Tuo Y; Wan H; Luo F
BMC Pulm Med; 2023 Apr; 23(1):127. PubMed ID: 37072815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
